AJANTA PHARMA LTD.

NSE : AJANTPHARMBSE : 532331ISIN CODE : INE031B01049Industry : Pharmaceuticals & DrugsHouse : Vimal Agrawal
BSE2081.752.05 (+0.1 %)
PREV CLOSE ( ) 2079.70
OPEN PRICE ( ) 2063.45
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1788
TODAY'S LOW / HIGH ( )2063.45 2103.50
52 WK LOW / HIGH ( )1240.55 2355.05
NSE2085.406.55 (+0.32 %)
PREV CLOSE( ) 2078.85
OPEN PRICE ( ) 2078.85
BID PRICE (QTY) 2085.40 (2)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 34465
TODAY'S LOW / HIGH( ) 2069.15 2107.95
52 WK LOW / HIGH ( )1246.75 2353.95
Quarters
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
11051.50
10284.40
10210.40
8818.40
Total Expenditure
7910.80
7377.80
7497.20
7324.70
PBIDT (Excl OI)
3140.70
2906.60
2713.20
1493.70
Other Income
135.90
213.30
317.50
368.30
Operating Profit
3276.60
3119.90
3030.70
1862.00
Interest
24.90
23.40
8.50
11.30
Exceptional Items
NA
NA
NA
NA
PBDT
3251.70
3096.50
3022.20
1850.70
Depreciation
342.60
337.10
331.80
330.20
Profit Before Tax
2909.10
2759.40
2690.40
1520.50
Tax
808.80
806.40
609.20
298.00
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
2100.30
1953.00
2081.20
1222.50
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
2100.30
1953.00
2081.20
1222.50
Minority Interest
NA
NA
NA
NA
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
2100.30
1953.00
2081.20
1222.50
Equity Capital
252.70
252.70
252.70
252.70
Face Value (IN RS)
2.00
2.00
2.00
2.00
Reserves
NA
NA
NA
NA
Calculated EPS
16.62
15.46
16.47
9.68
Calculated EPS (Annualised)
66.49
61.83
65.89
38.70
No of Public Share Holdings
42542601.00
42542601.00
42542601.00
43427138.00
% of Public Share Holdings
33.79
33.79
33.79
33.89
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
28.42
28.26
26.57
16.94
PBIDTM%
29.65
30.34
29.68
21.11
PBDTM%
29.42
30.11
29.60
20.99
PBTM%
26.32
26.83
26.35
17.24
PATM%
19.00
18.99
20.38
13.86
 
Notes
Notes
Notes
Notes
ATTENTION INVESTORSKYCIPO
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.